The Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes

Oncogene

Volumn 34, Issue 11, 2015, Pages 1363-1374

  O'Flanagan, C H ^a   Morais, V A ^b,c   Wurst, W ^d,e,f   De Strooper, B ^b,c,g   O'Neill, C ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CCND1 PROTEIN, HUMAN; CYCLIN D1; DNM1L PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE; MICROTUBULE ASSOCIATED PROTEIN; MITOCHONDRIAL PROTEIN; PROTEIN KINASE; PTEN-INDUCED PUTATIVE KINASE; SMALL INTERFERING RNA;

ANIMAL; BIOSYNTHESIS; CELL DIVISION; CELL MOTION; CELL PROLIFERATION; CYTOKINESIS; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; HUMAN; KNOCKOUT MOUSE; M PHASE CELL CYCLE CHECKPOINT; MCF 7 CELL LINE; METABOLISM; MITOCHONDRION; MOUSE; PARKINSON DISEASE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; CYTOKINESIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP PHOSPHOHYDROLASES; HELA CELLS; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MCF-7 CELLS; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEOPLASM INVASIVENESS; PARKINSON DISEASE; PROTEIN KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84896691095     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.81     Document Type: Article

References (70)

1. Unoki M, Nakamura Y. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 2001; 20: 4457-4465.
2. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S et al. Hereditary early-onset Parkinson 's disease caused by mutations in PINK1. Science 2004; 304: 1158-1160.
3. Dodson MW, Guo M. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol 2007; 17: 331-337.
4. Gispert S, Ricciardi F, Kurz A, Azizov M, Hoepken H-H, Becker D et al. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PloS One 2009; 4: e5777.
5. Haque ME, Thomas KJ, D'Souza C, Callaghan S, Kitada T, Slack RS et al. Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci USA 2008; 105: 1716-1721.
6. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M et al. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem 2005; 280: 34025-34032.
7. Kitada T, Pisani A, Porter DR, Yamaguchi H, Tscherter A, Martella G et al. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci USA 2007; 104: 11441-11446.
8. Wang H-L, Chou A-H, Yeh T-H, Li AH, Chen Y-L, Kuo Y-L et al. PINK1 mutants associated with recessive Parkinson 's disease are defective in inhibiting mitochondrial release of cytochrome c. Neurobiol Dis 2007; 28: 216-226.
9. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM et al. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Human Mol Genet 2005; 14: 3477-3492.
10. Cardona F, Sánchez-Mut JV, Dopazo H, Pérez-Tur J. Phylogenetic and in silico structural analysis of the Parkinson disease-related kinase PINK1. Hum Mutat 2011; 32: 369-378.
11. Gandhi S, Muqit MMK, Stanyer L, Healy DG, Abou-Sleiman PM, Hargreaves I et al. PINK1 protein in normal human brain and Parkinson's disease. Brain 2006; 129: 1720-1731.
12. Liu W, Acín-Peréz R, Geghman KD, Manfredi G, Lu B, Li C. Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc Natl Acad Sci USA 2011; 108: 12920-12924.
13. Sandebring A, Thomas KJ, Beilina A, Van der Brug M, Cleland MM, Ahmad R et al. Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS One 2009; 4: e5701.
14. Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, Vanbrabant M et al. Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 2009; 1: 99-111.
15. Pridgeon JW, Olzmann Ja, Chin L-S, Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 2007; 5: e172.
16. Arena G, Gelmetti V, Torosantucci L, Vignone D, Lamorte G, De Rosa P et al. PINK1 protects against cell death induced by mitochondrial depolarization, by phosphorylating Bcl-xL and impairing its pro-apoptotic cleavage. Cell Death Differ 2013; 20: 920-930.
17. Murata H, Sakaguchi M, Jin Y, Sakaguchi Y, Futami J, Yamada H et al. A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2. J Biol Chem 2011; 286: 7182-7189.
18. Akundi RS, Zhi L, Büeler H. PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis. Neurobiol Dis 2012; 45: 469-478.
19. Rakovic A, Grünewald A, Kottwitz J, Brüggemann N, Pramstaller PP, Lohmann K et al. Mutations in PINK1 and Parkin impair ubiquitination of mitofusins in human fibroblasts. PLoS One 2011; 6: e16746.
20. Klinkenberg M, Thurow N, Gispert S, Ricciardi F, Eich F, Prehn JHM et al. Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress. Neuroscience 2010; 166: 422-434.
21. Muqit MMK, Abou-Sleiman PM, Saurin AT, Harvey K, Gandhi S, Deas E et al. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem 2006; 98: 156-169.
22. Michiorri S, Gelmetti V, Giarda E, Lombardi F, Romano F, Marongiu R et al. The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ 2010; 17: 962-974.
23. Kawajiri S, Saiki S, Sato S, Sato F, Hatano T, Eguchi H et al. PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy. FEBS Lett 2010; 584: 1073-1079.
24. Berthier A, Navarro S, Jiménez-Sáinz J, Roglá I, Ripoll F, Cervera J et al. PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells. Human Pathol 2011; 42: 75-87.
25. Martin SA, Hewish M, Sims D, Lord CJ, Ashworth A. Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancers. Cancer Res 2011; 71: 1836-1848.
26. MacKeigan JP, Murphy LO, Blenis J. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 2005; 7: 591-600.
27. Mei Y, Zhang Y, Yamamoto K, Xie W, Mak TW, You H. FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation. Proc Natl Acad Sci USA 2009; 106: 5153-5158.
28. Jin SM, Youle RJ. PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci 2012; 125: 795-799.
29. Wilhelmus M, Nijland P. Involvement and interplay of Parkin, PINK1 and DJ1 in neurodegenerative and neuroinflammatory disorders. Free Radic Biol Med 2012; 53: 983-992.
30. Fujiwara M, Marusawa H, Wang H-Q, Iwai a, Ikeuchi K, Imai Y et al. Parkin as a tumor suppressor gene for hepatocellular carcinoma. Oncogene 2008; 27: 6002-6011.
31. Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I et al. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet 2010; 42: 77-82.
32. Sun X, Liu M, Hao J, Li D, Luo Y, Wang X et al. Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation. Cell Cycle 2013; 12: 1133-1141.
33. Bagchi A, Mills AA. The quest for the 1p36 tumor suppressor. Cancer Res 2008; 68: 2551-2256.
34. Bernard D, Monte D, Vandenbunder B, Abbadie C. The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD. Oncogene 2002; 21: 4392-4402.
35. Chaiwatanasirikul KA, Sala A. The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60. Cell Death Dis 2011; 2: e219.
36. Youle RJ, Karbowski M. Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 2005; 6: 657-663.
37. Youle RJ, Van der Bliek AM. Mitochondrial fission, fusion, and stress. Science 2012; 337: 1062-1065.
38. Chatterjee A, Mambo E, Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene 2006; 25: 4663-4674.
39. Grandemange S, Herzig S, Martinou J-C. Mitochondrial dynamics and cancer. Semin Cancer Biol 2009; 19: 50-56.
40. Favre C, Zhdanov a, Leahy M, Papkovsky D, O'Connor R. Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells. Oncogene 2010; 29: 3964-3976.
41. Barbosa IA, Machado NG, Skildum AJ, Scott PM, Oliveira PJ. Mitochondrial remodeling in cancer metabolism and survival: Potential for new therapies. Biochim Biophy Acta 2012; 1826: 238-254.
42. Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA 2008; 105: 1638-1643.
43. Deng H, Dodson MW, Huang H, Guo M. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA 2008; 105: 14503-14508.
44. Poole AC, Thomas RE, Yu S, Vincow ES, Pallanck L. The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS One 2010; 5: e10054.
45. Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K, Lämmermann K et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 2009; 284: 22938-22951.
46. Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 2007; 282: 11521-11529.
47. Kashatus DF, Lim K-H, Brady DC, Pershing NLK, Cox AD, Counter CM. RALA and RALBP1 regulate mitochondrial fission at mitosis. Nature Cell Biol 2011; 13: 1108-1115.
48. Horn SR, Thomenius MJ, Johnson ES, Freel CD, Wu JQ, Coloff JL et al. Regulation of mitochondrial morphology by APC/CCdh1-mediated control of Drp1 stability. Mol Biol Cell 2011; 22: 1207-1216.
49. Mitra K, Wunder C, Roysam B, Lin G, Lippincott-Schwartz J. A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proc Natl Acad Sci USA 2009; 106: 11960-11965.
50. Rambold AS, Kostelecky B, Elia N, Lippincott-Schwartz J. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc Natl Acad Sci USA 2011; 108: 10190-10195.
51. Gomes LC, Di Benedetto G, Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol 2011; 13: 589-598.
52. Beilina A, Van Der Brug M, Ahmad R, Kesavapany S, Miller DW, Petsko G et al. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci USA 2005; 102: 5703-5708.
53. Cho K, Ryu SJ, Oh YS, Park JH, Lee JW, Kim H-P et al. Morphological adjustment of senescent cells by modulating caveolin-1 status. J Biol Chem 2004; 279: 42270-42278.
54. Dagda RK, Cherra SJ, Kulich SM, Tandon A, Park D, Chu CT. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 2009; 284: 13843-13855.
55. Smirnova E, Griparic L, Shurland DL, Van der Bliek a M. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 2001; 12: 2245-2256.
56. Yamano K, Youle RJ. Coupling mitochondrial and cell division. Nat Cell Biol 2011; 13(9): 1026-1027.
57. Marongiu R, Spencer B, Crews L, Adame A, Patrick C, Trejo M et al. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J Neurochem 2009; 108: 1561-1574.
58. Heeman B, Van den Haute C, Aelvoet S-A, Valsecchi F, Rodenburg RJ, Reumers V et al. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. J Cell Sci 2011; 124: 1115-1125.
59. Akundi RS, Huang Z, Eason J, Pandya JD, Zhi L, Cass WA et al. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice. PLoS One 2011; 6: e16038.
60. Park J, Lee G, Chung J. The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process. Biochem Biophys Res Comm 2009; 378: 518-523.
61. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
62. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006; 25: 1620-1628.
63. Bharadwaj R, Yu H. The spindle checkpoint, aneuploidy, and cancer. Oncogene 2004; 23: 2016-2027.
64. Burgess DJ. Aneuploidy stokes the fire. Nat Rev Cancer 2011; 11: 692.
65. Bonda DJ, Bajić VP, Spremo-Potparevic B, Casadesus G, Zhu X, Smith M a et al. Review: cell cycle aberrations and neurodegeneration. Neuropathol Appl Neurobiol 2010; 36: 157-163.
66. Herrup K. The involvement of cell cycle events in the pathogenesis of Alzheimer's disease. Alzheimers Res Ther 2010; 2: 13.
67. Herrup K, Yang Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci 2007; 8: 368-378.
68. Staropoli JF. Tumorigenesis and neurodegeneration: two sides of the same coin? BioEssays 2008; 30: 719-727.
69. Ayllón V, O'connor R. PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response. Oncogene 2007; 26: 3451-3461.
70. Liang C-C, Park AY, Guan J-L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007; 2: 329-333.